HSDT

Solana Company Class A Common Stock (DE) (HSDT)

Stock · NASDAQ · Health Care

$2.24as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

Solana Company Faces Analyst Target Shift and Rumor Collapse. Solana Company (HSDT) saw mixed analyst activity. Morgan Stanley cut its target to $6, while B. Riley lifted its to $4. Rumors of an Alpenglow mainnet launch fell apart after developers said 'No Alpenrush'. An options market analysis suggested a potential spike. The company also highlighted that its key metric is SOL per share.

Active signals

Support level
$1.64
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

What HSDT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown22-12.4%27%
Bollinger Band Breakout14-18.3%43%
Volume Spike12-12.8%42%
Any 20-session window (baseline)-12.2%34%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About HSDT

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to prov…

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Employees
21

Fundamentals

1-day range
$2.24$2.43
Market cap
$98.09M
P/E (trailing)
—
P/E (forward)
-20.55
EPS (trailing)
$-30.29
Dividend yield
—
Beta
0.97
Avg. volume
387.9K
Dividend pay date
January 4, 2021
52-week range
$1.19$16.81

How Solana Company Class A Common Stock (DE) Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$548.0KSG&A$23.13M (4220%)R&D$3.51M (641%)Cost of Revenue$500.0K (91%)HSDT

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Gross Profit$5.52M(1007%)
Operating Income-$243.84M(-44496%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$4
+78.6%
Median
$3.5
+56.2%
Low
$3
+33.9%

Solana Company Class A Common Stock (DE) Competitors

Chosen by industry and closest market cap.

  • HSDT
    Solana Company Class A Common Stock (DE)
    $2.24
    ▼ 4.68%
    Market cap $98.09MP/E —
    $1.19$16.81
  • HYPR
    Hyperfine Inc. Class A Common Stock
    $0.755
    ▼ 3.21%
    Market cap $97.48MP/E —
    $0.7536$2.22
  • OM
    Outset Medical Inc. Common Stock
    $3.94
    ▼ 3.43%
    Market cap $96.39MP/E —
    $2.84$15.94
  • NRXS
    Neuraxis Inc. Common Stock
    $7.7
    ▼ 0.52%
    Market cap $86.47MP/E —
    $2.21$9.33
  • VANI
    Vivani Medical Inc. Common Stock (DE)
    $1.12
    ▼ 2.61%
    Market cap $117.28MP/E —
    $0.9227$1.92
  • STEX
    Streamex Corp. Common Stock
    $0.374
    ▼ 8.33%
    Market cap $75.35MP/E —
    $0.3876$6.5
  • STXS
    Stereotaxis Inc. Common Stock
    $1.01
    ▼ 3.81%
    Market cap $133.19MP/E —
    $1.02$3.2

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
3.23M
Disposed
2.91M

Institutional Ownership

March 31, 2026

Total shares held
15.29M
Total value held
$26.36M
Institutional holders
46
Top holders this quarter
  • Unknown4.59M
  • Unknown3.89M
  • Unknown1.08M
  • Unknown658.9K
  • Unknown581.3K
  • Unknown547.3K
  • Unknown461.2K
  • Unknown436.0K
  • Unknown370.6K
  • Unknown344.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.